COL7A1 and recessive dystrophic epidermolysis bullosa: Herpes simplex virus 1 has been proposed as a vector in a topical cream (KB103) for treatment of RDEB (107), where the episomal expression of COL7A1 protein in both keratinocytes and fibroblasts underneath the lesion can be palliative (NCT03536143).